QurAlis
Developing precision therapeutics for ALS and other neurodegenerative diseases, targeting novel mechanisms.
Developing precision therapeutics for ALS and other neurodegenerative diseases, targeting novel mechanisms.
The leading provider of enterprise-class all-flash storage, delivering unparalleled cost efficiency and the industry’s only guaranteed effective capacity.
Developing breakthrough therapies for rare and severe disorders.
Development of drug delivery systems which utilize nucleic acid.
Armagen ia a clinical stage biotechnology company focused on developing novel treatments for severe neurological disorders.
Actimis is a biopharmaceutical company focused on development of novel therapeutics for respiratory and inflammatory disorders such as asthma and rheumatoid arthritis.
Developing an ultra-efficient engine architecture that provides 30%-50% improvement in fuel economy without the typical cost drawback.
Advances manufacturing technology through chemistry relating to a unique and reactive class of monomers commonly known as methylene malonates.
Proterra is a world leader in the design and manufacture of zero-emission vehicles that enable bus fleet operators to reduce operating costs and deliver clean, quiet transportation to the community.
Develops medical technologies to treat a variety of endourological conditions, including BPH, prostate cancer and kidney cancer.
Developing a library of compounds that target and protect the ECM (extracellular matrix) from illness or injury-related degradation.
Develops and sells security products to detect and eliminate advanced malware through big data endpoint detection and analysis.